Empowering Melatonin Therapeutics with Drosophila Models

Area of Science:

• Biochemistry
• Neuroscience
• Gerontology

Background:

• Melatonin is a key neurohormone regulating circadian rhythms, sleep, aging, and oxidative stress.
• Its functions are mediated through MT1/MT2 receptors and non-receptor pathways impacting mitochondrial health.
• Dysfunctional mitochondria are implicated in aging and various diseases, suggesting melatonin's therapeutic relevance.

Purpose of the Study:

• To review melatonin's diverse functions, focusing on conserved mechanisms.
• To explore the utility of model organisms, specifically *Drosophila*, in studying melatonin's therapeutic applications.
• To highlight melatonin's potential for treating neurodegenerative and renal diseases.

Main Methods:

• Literature review of melatonin's receptor-mediated and non-receptor-mediated functions.
• Analysis of functional conservation across species, with emphasis on model organism research.
• Examination of melatonin's role in mitochondrial function and antioxidant defense.

Main Results:

• Melatonin's functions in circadian rhythm, sleep, aging, and oxidative response are conserved.
• Non-receptor pathways involving mitochondria and antioxidant cascades are crucial.
• *Drosophila* models offer valuable insights into disease pathogenesis and drug discovery for melatonin therapeutics.

Conclusions:

• Melatonin possesses significant pharmacological potential due to its multifaceted roles.
• Understanding conserved functions and leveraging model organisms can advance melatonin-based therapies.
• Melatonin shows promise for treating age-related and degenerative conditions, including neurodegenerative and renal diseases.